{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:23:57Z","timestamp":1791908637212,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.atherosclerosis.2013.01.019","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T01:49:27Z","timestamp":1360028967000},"page":"217-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Clinical correlates of change in inflammatory biomarkers: The\u00a0Framingham Heart Study"],"prefix":"10.1016","volume":"228","author":[{"given":"Joao D.","family":"Fontes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer F.","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhayana","family":"Dallmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Rienstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate B.","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandran S.","family":"Vasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"John F.","family":"Keaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emelia J.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib1","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/archinte.165.21.2473","article-title":"C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study","volume":"165","author":"Wilson","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/01.HYP.0000256956.61872.aa","article-title":"Multiple biomarkers and the risk of incident hypertension","volume":"49","author":"Wang","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib4","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/CIRCULATIONAHA.104.482570","article-title":"Biomarkers of cardiovascular disease: molecular basis and practical considerations","volume":"113","author":"Vasan","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.CIR.99.2.237","volume":"99","author":"Koenig","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib6","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1161\/01.CIR.100.12.1280","article-title":"Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease","volume":"100","author":"Kugiyama","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib7","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/01.CIR.0000025636.03561.EE","article-title":"Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men","volume":"106","author":"Pradhan","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.amjmed.2008.08.023","article-title":"Long-term C-reactive protein variability and prediction of metabolic risk","volume":"122","author":"Chen","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(10)62038-7","article-title":"National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0\u00a0million participants","volume":"377","author":"Farzadfar","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib10","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0140-6736(10)62036-3","article-title":"National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4\u00a0million participants","volume":"377","author":"Danaei","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(10)62037-5","article-title":"National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1\u00a0million participants","volume":"377","author":"Finucane","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/oxfordjournals.aje.a112813","article-title":"An investigation of coronary heart disease in families. The Framingham Offspring Study","volume":"110","author":"Kannel","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib13","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/aje\/kwm021","article-title":"The third generation cohort of the national heart, lung, and blood institute's Framingham heart study: design, recruitment, and initial examination","volume":"165","author":"Splansky","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib14","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1161\/HYPERTENSIONAHA.107.105668","article-title":"Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection","volume":"51","author":"Schnabel","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCGENETICS.108.804245","article-title":"The relation of genetic and environmental factors to systemic inflammatory biomarker concentrations","volume":"2","author":"Schnabel","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.107.105668","article-title":"Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection","author":"Schnabel","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.amjcard.2009.02.053","article-title":"Relation of multiple inflammatory biomarkers to incident atrial fibrillation","volume":"104","author":"Schnabel","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib18","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","article-title":"Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib19","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000103131.70301.4F","article-title":"Inflammation as a risk factor for atrial fibrillation","volume":"108","author":"Aviles","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.CIR.97.5.425","article-title":"Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib21","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib22","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1161\/01.CIR.96.12.4219","article-title":"Circulating adhesion molecules VCAM-1, sICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"96","author":"Hwang","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib23","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/01.CIR.0000116761.93647.30","article-title":"Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study","volume":"109","author":"Schwedhelm","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib24","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM200010193431603","article-title":"Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group","volume":"343","author":"Packard","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib25","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jacc.2007.09.058","article-title":"Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes","volume":"51","author":"Omland","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/01.CIR.103.4.491","article-title":"Soluble P-selectin and the risk of future cardiovascular events","volume":"103","author":"Ridker","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/CIRCHEARTFAILURE.108.839613","article-title":"Lipoprotein-associated phospholipase A(2) and risk of congestive heart failure in older adults: the Cardiovascular Health Study","volume":"2","author":"Suzuki","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib28","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.jacc.2004.06.076","article-title":"Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction","volume":"44","author":"Ueland","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/STROKEAHA.107.513259","article-title":"Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) Study","volume":"40","author":"Nambi","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib30","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1161\/01.CIR.0000057810.48709.F6","article-title":"Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study","volume":"107","author":"Vasan","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1080\/00365510701283878","article-title":"Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease","volume":"67","author":"Halvorsen","year":"2007","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.atherosclerosis.2007.12.058","article-title":"Relation of smoking status to a panel of inflammatory markers: the Framingham Offspring","volume":"201","author":"Levitzky","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib33","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.107.710509","article-title":"Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study","volume":"116","author":"Pou","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.diabres.2004.11.007","article-title":"Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6","volume":"69","author":"Park","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib35","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/sj.ijo.0801792","article-title":"The relation of body fat mass and distribution to markers of chronic inflammation","volume":"25","author":"Festa","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib36","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/oby.2004.114","article-title":"Leukocyte migration in adipose tissue of mice null for sICAM-1 and Mac-1 adhesion receptors","volume":"12","author":"Robker","year":"2004","journal-title":"Obes Res"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib37","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1001\/jama.289.14.1799","article-title":"Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial","volume":"289","author":"Esposito","year":"2003","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archinte.167.1.31","article-title":"The effect of weight loss on C-reactive protein: a systematic review","volume":"167","author":"Selvin","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/01.ATV.17.2.310","article-title":"P-selectin and vascular cell adhesion molecule-1 are focally expressed in aortas of hypercholesterolemic rabbits before intimal accumulation of macrophages and T lymphocytes","volume":"17","author":"Sakai","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib40","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.ATV.19.5.1284","article-title":"Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2","volume":"19","author":"Ivandic","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/01.ATV.13.2.197","article-title":"An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium","volume":"13","author":"Li","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib42","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib43","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N.Engl.J Med"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.jhh.1001537","article-title":"Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence","volume":"17","author":"Bautista","year":"2003","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/01.HYP.0000226046.58883.32","article-title":"Valsartan, blood pressure reduction, and C-reactive protein: primary report of the Val-MARC trial","volume":"48","author":"Ridker","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib46","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCULATIONAHA.110.948570","article-title":"Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels","volume":"123","author":"Dehghan","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib47","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/01.CIR.100.7.713","article-title":"Hormone replacement therapy and increased plasma concentration of C-reactive protein","volume":"100","author":"Ridker","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib48","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/thx.2003.012468","article-title":"Acute effects of cigarette smoke on inflammation and oxidative stress: a review","volume":"59","author":"van der Vaart","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib49","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.ATV.0000058402.34138.11","article-title":"Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study","volume":"23","author":"Keaney","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib50","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.atherosclerosis.2008.06.031","article-title":"Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: the Framingham Offspring Study","volume":"203","author":"Murabito","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.01.019_bib51","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/hrt.2007.118794","article-title":"Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality","volume":"94","author":"Currie","year":"2008","journal-title":"Heart"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013000543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013000543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T07:13:02Z","timestamp":1562656382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915013000543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0021915013000543"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.01.019","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical correlates of change in inflammatory biomarkers: The\u00a0Framingham Heart Study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}